@LisaA

CEO of @adela_bio. Co-Founder of @GenomeMed and Clarified Precision Med. Board member | Advisor | Serial #entrepreneur. Global speaker on #Genomics.

 South San Francisco, CA
genomemedical.com
Joined August 2007
  • Tweets495
  • Following1.7K
  • Followers1.3K
47Media
Lisa Alderson retweeted
Adela@adela_bioMay 27
We’re excited to share that Adela will highlight progress from our MCED study @ASCO 2026. prnewswire.com/news-releases… #ASCO26
2
1
98
Lisa Alderson retweeted
Adela@adela_bioJun 1
At Adela, we're proud to share our latest research on a #tissuefree #methylation-based #MRD assay for #HNSCC at #ASCO26 (Poster #541).
1
1
46
Lisa Alderson retweeted
Adela@adela_bioJun 1
Proud to see our research being presented at #ASCO2026 as we continue our mission to transform cancer care through innovative blood-based testing. We welcome the opportunity to connect with colleagues, collaborators, and new partners throughout #ASCO26. #LiquidBiopsy #Adela
1
1
41
Lisa Alderson retweeted
Adela@adela_bio30 May 2025
We're excited to announce two presentations at #ASCO25 demonstrating the ability of Adela's tissue-agnostic test for MRD Detection and Response Monitoring to predict progression and identify non-responders to immunotherapy in solid tumors. prnewswire.com/news-releases…
1
3
135
Lisa Alderson retweeted
Adela@adela_bioMay 4
Looking forward to engaging with the oncology community on how #liquidbiopsy and tissue-free approaches are advancing cancer detection and monitoring across the cancer continuum #ASCO26 If you’re attending, let’s connect. #Oncology #Adela @ASCO @ConquerCancerFd @OncUpdates
🤖 Made with AI
1
1
94
Heading to Precision Med #TRICON in San Diego? Catch Partner Mara Aspinall at two key sessions: 📅 3/11 | 3:40 PM PT – Driving Innovation in Precision Medicine 📅 3/12 | 8:00 AM PT – Investing in Precision Medicine More info: triconference.com/ @TriConference
1
1
2
1,093
Lisa Alderson retweeted
Adela@adela_bio19 Mar 2024
Adela is presenting at #AACR2024! Highlights include data in head & neck cancer from our tissue-agnostic MRD assay, and Chief Scientific Officer @decarvalho_lab chairing the Plenary Session “Discovery Science in Early Cancer Biology and Interception”. adelabio.com/press/adela-to-…
1
1
449
Lisa Alderson retweeted
Adela@adela_bio19 Oct 2023
Adela will be presenting data at #ESMO23 demonstrating strong prognostic prediction capabilities of our genome-wide methylome enrichment platform in Head and Neck Cancer and Renal Cell Carcinoma adelabio.com/press/adela-pre…

ADELA | Adela Presents Data Demonstrating Strong Prognostic Prediction Capabilities in Head and...

Individuals with higher quantities of circulating tumor DNA (ctDNA) prior to treatment had a significantly increased likelihood of recurrence or progression. Adela’s tissue-agnostic platform shows...

adelabio.com
1
1
2
762
I'm excited to share ep. 1 of Closing Time is live! Tune in as @LisaA pitches her new startup to @Lux_Capital General Partner @deenashakir. Co-hosted with my longtime friend @halletecco, Closing Time gives a unique view into the exciting world of healthcare startups.
Fenwick@FenwickWest16 Aug 2023
Tune in to ep. 1 of Closing Time, a podcast letting listeners listen in on a startup pitch. Clarified Precision Medicine Co-Founder & Strategic Advisor @LisaA & @Lux_Capital General Partner @deenashakir join @halletecco & @mtesquivel: ow.ly/s6vt50PzZ7m
2
6
1,657
This large study from our colleagues in China, show that 20% of women with ovarian insufficiency have genetic changes that explain their disease. It's time to offer genome sequencing to women with this form of infertility. @UCSF_ObGynRS @NatureMedicine nature.com/articles/s41591-0…

Landscape of pathogenic mutations in premature ovarian insufficiency

Nature Medicine - Whole-exome sequencing analyses in a cohort of 1,030 patients with premature ovarian insufficiency identify new likely pathogenic variants and reveal distinct genetic...

nature.com
1
8
14
1,410
Lisa Alderson retweeted
Susan Tousi@susantousi16 Feb 2023
Great to be back in Asia feeling the culture, friendship & hospitality of our team & partners as we talk about the role of #genomics, including reconnecting with Peter Tsai after our talk at IGF about how he’s scaling Taiwan’s precision medicine. news.gbimonthly.com/tw/artic…
1
15
1,011
Lisa Alderson retweeted
Muin J. Khoury@MuinJKhoury9 Oct 2022
This @GenomeMedicine study found that many patients did not understand the numbers representing polygenic risk, and that primary care providers saw polygenic risk information as a natural extension of their current practice. genomemedicine.biomedcentral…
1
7
25
Finally got to watch this incredible conversation from last week's #IlluminaGenomicsForum. I just can't believe who I married. Such a profound and sincere message of hope, delivered with humility and humor. That other guy is pretty cool too.
10
14
2
270
Lisa Alderson retweeted
Illumina
@illumina1 Oct 2022
#IGF 2022: ✔️

The Illumina Genomics Forum: Final Recap

Sarah Vedas, Senior Director at Illumina, recaps the Illumina Genomics Forum.

1
4
2
27
5 years of work. 40+ patents. 1500+ incredible colleagues. Worth the wait! Watch the video to learn more about @Illumina’s new #NovaSeqX Series. #IGF #Genomics4Good – at San Diego, CA
Illumina
@illumina29 Sep 2022
Replying to @illumina
But that’s not all, we’re thrilled to introduce you to our most innovative sequencing platform ever developed: Meet the #NovaSeq™ X Series. This. Changes. Everything.
19
1
111
On Sept. 7 the NCCN testing guidelines for breast cancer were updated and within a week our teams ensured the updates were reflected in our RISE Module so providers could make timely care decisions based on the latest national care guidelines. hubs.li/Q01ngmR_0
2
6
Lisa Alderson retweeted
Kevin Keegan@keegan_ke28 Sep 2022
Amazing panel discussion at #IGF on Clinical Genomics - the time is NOW! @illumina @EricTopol @francesarnold @WohlgemuthJay
2
4
26
The genome is our future. Join me & amazing lineup of speakers (Obama, Bill Gates and 50+ other) at Illumina Genomics Forum that starts tomorrow. It’s time to accelerate targeted therapies & cures for rare diseases like adrenal cancer. Learn more (illumina.com/events/genomics…) #IGF
10
1
25
Inspiring speech by ⁦@fdesouza⁩ ‘Genomics should not be the tool for diagnostics of the rich and lucky’ We need to increase representation of non European ancestry, < 2% of genomes are from African descent in spite of being close to 20% of world population.
3
29
1
92
Hybrid health care models increase efficiency, engage patients and help overcome access barriers. This week Lisa Alderson presents Making Genomics Available to All at #OWHIC.We’re excited to lead the discussion on how tech is breaking down barriers to care hubs.li/Q01mGtbz0
1
1
4
Load more